Multiple Myeloma: Understanding My Treatment Options
Topics Covered
We invite you to learn more about:
- Treatment options for myeloma
- Clinical trials for myeloma, including CAR T-cell therapy
- How myeloma can affect a patient’s quality of life
- Questions to ask your healthcare team
Speaker
Amrita Y. Krishnan, MD
Professor, Department of Hematology & Hematopoietic Cell Transplantation
Director, Judy and Bernard Briskin Center for Multiple Myeloma Research
City of Hope Medical Center
Duarte, CA
Audio Replay
Program Materials
Program Support
Support for this program is provided by Bristol-Myers Squibb, Genentech & Biogen, Takeda Oncology, and The Leukemia & Lymphoma Society.
Chronic Myeloid Leukemia: Know Your Options
Topics Covered
We invite you to learn more about:
- Treatment advances for chronic myeloid leukemia (CML)
- Monitoring CML
- Treatment-free remission
- Side-effects management
- Discussing quality-of-life issues with my healthcare team
Speaker
Kendra Sweet, MD, MS
Assistant Member, Department of
Malignant Hematology
Moffitt Cancer Center
Tampa, FL
Audio Replay
Program Materials
Program Support
Support for this program provided by Bristol-Myers Squibb, Novartis, and Takeda Oncology.
The Future of Myeloma Treatment: What’s Next?
Topics Covered
We invite you to learn more about:
- Current myeloma treatments
- What the future holds for myeloma treatment
- Side-effect management
Program Materials
Program Slides (PDF)
Slides with Transcript (PDF)
Speaker
C. Ola Landgren, MD, PhD
Professor of Medicine
Chief, Division of Myeloma, Department of Medicine
Director, Sylvester Myeloma Institute
Co-Leader, Translational and Clinical Oncology Program
Paul J. DiMare Endowed Chair in Immunotherapy
Sylvester Comprehensive Cancer Center
University of Miami
Miami, FL
Program Support
Support for this program provided by AbbVie Inc.; Genentech, a member of the Roche Group; GSK plc; Johnson & Johnson; and Sanofi.
Blood Cancer 101: The Basics on Disease, Treatment, and the Role of the HCP
Also available in Spanish: Introducción al cáncer de la sangre: Aspectos básicos sobre la enfermedad, el tratamiento y el rol del profesional médico
Date of initial release: August 7, 2024
Valid for CE credit through: February 11, 2026
1.25 CE Credits/Contact hours for nurses and social workers
Format: Noninteractive recorded webinar
Description
This webinar will provide an overview of blood cancers. Treatment, side effects, psychosocial and financial impacts of a blood cancer diagnosis will be discussed. The role of social workers, nurses and other members of the healthcare team, along with resources for patient and caregiver education and support will be highlighted.
Target Audience
Oncology social workers, nurses, psychologists, and other healthcare professionals involved in the care of patients with hematologic malignancies.
Course content level for social workers: beginner and intermediate
Learning Objectives
After completing this activity, participants will be able to:
- Describe the different blood cancers, including diagnosis and treatment
- Describe the psychosocial impact of a blood cancer diagnosis
- Explain the role of the social worker, nurse and other members of the healthcare team
- Educate patients and caregivers about clinical trial participation
- List resources for patients with blood cancers and how to access them
Faculty
Laura Romundstad, CRNP, MSN, RN
Lynn Steele, LSW, OSW-C
Information Specialist
Information Resource Center
The Leukemia & Lymphoma Society
Continuing Education (CE) Information
Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.25 continuing education contact hours through the California Board of Registered Nursing.
Social Work Credit Designation
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.25 clinical continuing education credits.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.25 clinical CE contact hours for this activity.
Method of Participation
Participants must review the webcast in its entirety and complete the evaluation and pass the post-test to obtain CE credit. After completing this process you will receive your certificate by email.
All continuing education credits are provided free of charge.
Provider
This activity is provided by The Leukemia & Lymphoma Society.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: [email protected].
Clinician Strategies and Resources: Caring for AYAs as they Transition to Cancer Survivorship
Recorded on: May 9, 2024
1 CE Credit/Contact hour for nurses and social workers available until: December 17, 2025
Format: Non-interactive recorded webinar
Target Audience
This accredited activity is intended for hematologist/oncologists, APPs, nurses, social workers, and other healthcare professionals involved in the care of adolescent and young adult (AYA) patients with cancer and cancer survivors.
Description
This webinar, featuring a panel of subject matter experts, addresses the unique challenges faced by adolescents and young adults (AYAs) with cancer as they transition into survivorship, emphasizing interdisciplinary care and long-term support. Resources to support AYAs, their caregivers, and healthcare professionals will also be provided.
Educational Objectives
After completing this accredited activity, the participant should be better able to:
- Describe care challenges for AYAs as they transition to survivorship
- Explain the importance of survivorship care, including late effects and how to access long-term follow-up guidelines
- Identify interdisciplinary care team roles in supporting AYA cancer survivors
- Review resources to support AYAs with cancer, their caregivers, and healthcare professionals
Faculty
Rebecca Eary, DO, MPH
Assistant Professor, Department of Family and Community Medicine
UT Southwestern Medical School
Medical Director, Primary Care Cancer Survivorship Clinic and the After Cancer Experience (ACE) Adult Program for Adolescent and Childhood Cancer Survivors
Dallas, TX
Danielle Friedman, MD, MS
Associate Member
Department of Pediatrics, MSK Kids
Director, Pediatric Long-Term Follow-Up Program
Director, Pediatric Survivorship Fellowship
Memorial Sloan Kettering Cancer Center
New York, NY
Brittany Hall, PhD
Associate Professor
UT Southwestern Medical Center
Dallas, TX
Michelle Rajotte, LMSW (Moderator)
Associate Director
Information Resource Center
The Leukemia & Lymphoma Society
Rye Brook, NY
Michael Roth, MD
Professor of Pediatrics
Medical Director, Cancer Survivorship
Co-Director, Adolescent and Young Adult Oncology Program
Director, Childhood Cancer Survivorship Program
University of Texas M.D. Anderson Cancer Center
Chair, Children’s Oncology Group AYA Oncology Discipline Committee
Houston, TX
Angela Yarbrough, DNP, APRN, FNP-BC, CPHON
Nurse Practitioner
University of Texas M.D. Anderson Cancer Center
Houston, TX
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society. Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurse Practitioner Continuing Education
Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
Social Worker Continuing Education
As a Jointly Accredited Organization, Medical Learning Institute, Inc. (MLI) is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.0 Clinical Social Work continuing education credit.
Interprofessional Continuing Education Credit
Method of participation
There are no fees for participating in or receiving credits for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit.
If you have questions regarding your certificate, please contact Nicole Dane via email at [email protected].
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute, Inc., in collaboration with The American Cancer Society.
Supporters
There is no commercial support associated with this activity.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at [email protected].